ASS1 and central nervous system cancer: Meanwhile, the half-lives of pre-ASS1 and mature mRNAs in glioma cells overexpressing METTL14 were significantly reduced, which indicated that METTL14 could promote the splicing of precursor mRNA and the degradation of ASS1 mature mRNA.